|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.
The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on April 21, 2021. The analyst firm set a price target for 40.00 expecting ACRS to rise to within 12 months (a possible 117.63% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $18.38 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aclaris Therapeutics.
There is no upcoming split for Aclaris Therapeutics.
Aclaris Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.